Sensorion announces two presentations at AAO-HNSF 2019 in New Orleans. pdfread

Sensorion announces three presentations at IEB 2019 in Padua. pdfRead

Sensorion announces appointment of John Furey, former COO of Spark Therapeutics, as independent board member. pdfRead

Sensorion: reporting of the General Assembly - Appointment of three new directors. pdfRead

Sensorion receives FDA IND approval for Arazasetron (SENS-401). pdfRead

Next events